This article was reviewed by Darragh O’Carroll, MD. Oral vs. Injectable Semaglutide: Effectiveness & Side Effects Key ...

Clinicians prescribing GLP-1 agents should ask about sexual function and consider medication review if new anorgasmia appears.

This came after the drug major Sun Pharma Laboratories presented the proposal to conduct Phase III clinical trial titled “A Multicenter, Randomized, Double-Blind, Double-Dummy, Active-Controlled, ...

Experimental pill versions of GLP-1 weight loss drugs by Novo Nordisk and Eli Lilly will receive FDA priority review. Read ...

Thirteen drugs for cancer and diabetes have been added to the list of essential medicines exempted from value-added tax or ...

Novo Nordisk's Rybelsus gets US FDA approval for CV risk reduction in adults with type 2 diabetes who are at high risk, including those who have not had a prior CV event: Plainsbo ...

According to DataM Intelligence, the Glucagon-like Peptide-1 (GLP-1) Analogues Market is witnessing a transformative ...

Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...

This article was reviewed by Darragh O’Carroll, MD. Ozempic Alternatives for Weight Loss Key takeaways: Ozempic® alternatives ...

The FDA has approved Rybelsus, the first oral GLP-1 receptor agonist, to reduce cardiovascular risk in type 2 diabetes ...

The US president’s sudden policy reversal on weight-loss drugs like Ozempic and Wegovy could reshape the global market, from ...

A new University College London study featuring 17,604 participants age 45 and up discovered that semaglutide -- a GLP-1 agonist found in weight-loss drugs like Ozempic and Wegovy -- decreases the ...